PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Feb-2023 NEOGENOMICS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NeoGenomics, Inc. and Encourages Investors to Contact the Firm Businesswire
04-Feb-2023 U.S. FDA Approves Takeda’s TAKHZYRO® (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older Businesswire
04-Feb-2023 Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0676 in B-cell Malignancies Businesswire
04-Feb-2023 Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
03-Feb-2023 Medidata Experts Present New Insights on Risk-Based Quality Management, Decentralized Clinical Trials, and Real World Data at SCOPE Summit Businesswire
03-Feb-2023 IV Poles Market is expected to reach US$ 306.1 Million by the end of 2029 MARKITWIRED
03-Feb-2023 Eye Tracking System Market is projected to register a high CAGR of 26.6% through 2028 MARKITWIRED
03-Feb-2023 Ibuprofen API Market is estimated to progress at a CAGR of 3% through 2029 MARKITWIRED
03-Feb-2023 Vacuum Blood Collection Devices Market is expected to reach US$ 4.2 Billion by 2031 MARKITWIRED
03-Feb-2023 Needle-Free Injectors Market to expand at a 12% value CAGR by 2032 MARKITWIRED
03-Feb-2023 Manometry Systems Market is expected to register a CAGR of 5.4% through 2031 MARKITWIRED
03-Feb-2023 Promotions and Team Expansion Mark the Start of a New Year at Leason Ellis Businesswire
03-Feb-2023 FOXO Technologies Appoints Taylor Fay as Chief Operating Officer Businesswire
03-Feb-2023 Former NFL standout, Rob Sims, and Pro Football Hall of Fame Member, Calvin Johnson Jr., Launch Primitiv Performance™ Line of nano-CBD Products Businesswire
03-Feb-2023 Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Businesswire
03-Feb-2023 Ambrx Biopharma Strengthens Clinical Leadership with Appointment of Sandra Aung, Ph.D. as Head of Clinical Development Businesswire
03-Feb-2023 New Talk About It Resources Aim to Accelerate Integration of Mental Health into Quality Cancer Care Businesswire
03-Feb-2023 Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Therapy for Advanced or Recurrent Endometrial Carcinoma Businesswire
03-Feb-2023 KalVista Pharmaceuticals to Present at SVB Securities Global Biopharma Conference Businesswire
03-Feb-2023 IMFINZI (DURVALUMAB) IN COMBINATION WITH GEMCITABINE AND CISPLATIN APPROVED IN GREAT BRITAIN AS A FIRST-LINE TREATMENT FOR ADULT PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC BILIARY TRACT CANCER AstraZeneca